News | January 24, 2008

New Catheter Beats Out Others on Blood Flow at Seven Weeks

January 25, 2008 – AngioDynamics’ recently launched self-centering, tunneled hemodialysis access catheter showed better flow rates at seven weeks of use compared to competitive catheters, according to a preliminary study of Centros.

This preliminary study was presented by Stephen R. Ash, M.D., FACP, on January 23, 2008, at the International Symposium for Endovascular Therapy (ISET) in Hollywood, FL. Dr. Ash, who designed Centros. The study indicated not only that the self-centering catheter provides highly acceptable flow rates at modest negative pressure without deterioration in flow rate over seven weeks of use, but even with tips positioned in the superior vena cava (SVC) rather than within the atrium. Flow rate for Centros at the seven week follow-up point was 401mL/min, compared to the control group of competitive catheters at 348mL/min. (p

Centros is a self-centering, tunneled hemodialysis access catheter that has a curved configuration that allows it to be placed in the superior vena cava in a centered position, without touching the vein walls. Rather than being placed in the atrium, the tip of the catheter is placed in the lower third of the superior vena cava.

“Centros changes the conventional catheter paradigm from a line to a plane, meaning the catheter fits into a cylinder in the middle of the vein and won’t lie in contact against the vein wall like prevalent dual-lumen tunneled dialysis catheters,” said Dr. Ash. “Contact with the vein wall often results in sheathing or clots, which can easily obstruct the ports. While a large clinical study will more fully document the benefits of this new design approach, the preliminary study gives us confidence that Centros will have long-term advantages for patients.”

For more information: www.angiodynamics.com

Related Content

Reflow Medical's Wingman Crossing Catheter Receives FDA Clearance for Coronary Indication
News | Catheters| October 02, 2017
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S.
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
Teleflex, FDA 510k clearance, TrapLiner Catheter, U.S. launch
Technology | Catheters| March 02, 2017
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
Merit Medical Systems, SwiftNINJA Steerable Microcatheter, FDA 510(k) clearance
Technology | Catheters| November 09, 2016
November 9, 2016 — Merit Medical Systems Inc.
VentureMed Group, Flex Scoring Catheter, FDA approval, peripheral arterial disease, PAD, endovascular treatment
Technology | Catheters| July 13, 2016
July 13, 2016 — VentureMed Group Ltd., specializing in devices for the endovascular treatment of...
Roxwood Medical, MicroCross Catheter, full U.S. launch

Image courtesy of Roxwood Medical

Technology | Catheters| January 07, 2016
Roxwood Medical Inc. reported that more than 500 patients have been successfully treated as part of the initial limited...
Overlay Init